Early menopause may be a risk factor for Alzheimer’s disease, but women who begin hormone therapy (HT) at the start of menopause do not have an increased risk of the condition, new research has suggested.
Women are more likely than men to develop Alzheimer’s and they make up two-thirds of the population living with it.
